Document is current
Any future updates will be listed below
-
Authors
Clarke, Megan
Ataya, Ali
Turkin, Alison M.
Parikh, Raj
Davis, Kyle
Miller, Chad E.
Kantorovich, Alexander
Winkler, Thomas
Cassady, Steven J.
-
Funding
Funding for this research was provided by:
United Therapeutics Corporation
- License Information
-
More Information
Article History
Received: 23 May 2025
Accepted: 7 October 2025
First Online: 10 November 2025
Change Date: 21 November 2025
Change Type: Update
Change Details: The original article was revised due to update in author affiliation.
Declarations
:
: Steven Cassady has served as a consultant for Iota Biosciences, Inc. Megan Clarke has participated on an Advisory Board with Janssen Pharmaceuticals. Ali Ataya has received consulting fees from United Therapeutics Corporation. Raj Parikh is a speaker for Janssen Pharmaceutical Companies of Johnson & Johnson and United Therapeutics and is a scientific advisory board member for United Therapeutics and Liquidia. Chad Miller has conducted research, consulted for, served on the speakers bureau and advisory board for United Therapeutics. He has conducted research and served on the speakers bureau and advisory board for Janssen. He has conducted research with Insmed and served on an advisory board and steering committee for Bayer. Alison Turkin, Kyle Davis, Alex Kantorovich, and Thomas Winkler are employees of and may have received stock or stock options from United Therapeutics.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
